Moderna has shipped approximately 55 million Covid-19 doses to the US to date, the company said Wednesday.
An additional approximately 33 million doses have been produced, filled into vials and are in the final stages of production and testing before being released to the US, Moderna said in a news release.
The company now plans to manufacture 700 million doses globally this year, an increase of 100 million doses. In 2022, it says its global capacity will increase to approximately 1.4 billion doses of Covid-19 vaccine.
Moderna said it is making new financial investments to achieve that increased capacity at manufacturing sites. The influx of money will enable additional production of Moderna's Covid-19 vaccine and potential production of new versions of the vaccine that may be needed to combat coronavirus variants.
The company said it could potentially manufacture even more doses in 2022 if studies show new variant-based versions of the vaccine can be administered at lower dosages than the current vaccine.